This Division requires the responsible person for certain brands of pharmaceutical items to comply with the price disclosure requirements for each supply of those brands of pharmaceutical items.

•   Subdivision B has the price disclosure requirements. It provides for regulations to set out the kind of information that is required to be provided for the brand of the pharmaceutical item, the form and manner in which that information is to be provided and when that information is to be provided.

•   The price disclosure requirements generally apply in relation to brands of pharmaceutical items that have a drug on F2.

•   Subdivision D provides for the consequences of failing to comply with the price disclosure requirements.

In addition, this Division reduces the approved ex - manufacturer price of the brand of the pharmaceutical item in specified circumstances (see Subdivision E). This reduction happens as a result of the price being adjusted based on information collected about brands of pharmaceutical items.